Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial von Fellström, Bengt C, Prof, Barratt, Jonathan, FRCP, Cook, Heather, PhD, Coppo, Rosanna, MD, Feehally, John, Prof, de Fijter, Johan W, Prof, Floege, Jürgen, Prof, Hetzel, Gerd, Prof, Jardine, Alan G, Prof, Locatelli, Francesco, FRCP, Maes, Bart D, Prof, Mercer, Alex, PhD, Ortiz, Fernanda, PhD, Praga, Manuel, Prof, Sørensen, Søren S, Prof, Tesar, Vladimir, Prof, Del Vecchio, Lucia, MD

Volltext

Performance of GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Statistical Simulation von Greene, Tom, Ying, Jian, Vonesh, Edward F, Tighiouart, Hocine, Levey, Andrew S, Coresh, Josef, Herrick, Jennifer S, Imai, Enyu, Jafar, Tazeen H, Maes, Bart D, Perrone, Ronald D, Del Vecchio, Lucia, Wetzels, Jack F M, Heerspink, Hiddo J L, Inker, Lesley A

Volltext

Early Change in Urine Protein as a Surrogate End Point in Studies of IgA Nephropathy: An Individual-Patient Meta-analysis von Inker, Lesley A., MD, MS, Mondal, Hasi, MPH, Greene, Tom, PhD, Masaschi, Taylor, BA, Locatelli, Francesco, MD, Schena, Francesco P., MD, Katafuchi, Ritsuko, MD, Appel, Gerald B., MD, PhD, Maes, Bart D., MD, Li, Philip K., MD, Praga, Manuel, MD, Del Vecchio, Lucia, MD, Andrulli, Simeone, MD, Manno, Carlo, MD, Gutierrez, Eduardo, MD, Mercer, Alex, PhD, Carroll, Kevin J., PhD, Schmid, Christopher H., PhD, Levey, Andrew S., MD

Volltext

Acute Treatment Effects on GFR in Randomized Clinical Trials of Kidney Disease Progression von Neuen, Brendon L, Tighiouart, Hocine, Heerspink, Hiddo J L, Vonesh, Edward F, Chaudhari, Juhi, Miao, Shiyuan, Chan, Tak Mao, Fervenza, Fernando C, Floege, Jürgen, Goicoechea, Marian, Herrington, William G, Imai, Enyu, Jafar, Tazeen H, Lewis, Julia B, Li, Philip Kam-Tao, Locatelli, Francesco, Maes, Bart D, Perrone, Ronald D, Praga, Manuel, Perna, Annalisa, Schena, Francesco P, Wanner, Christoph, Wetzels, Jack F M, Woodward, Mark, Xie, Di, Greene, Tom, Inker, Lesley A

Volltext

Mycophenolate mofetil in IgA nephropathy: Results of a 3-year prospective placebo-controlled randomized study von Maes, Bart D., Oyen, Raymond, Claes, Kathleen, Evenepoel, Pieter, Kuypers, Dirk, Vanwalleghem, Johan, Damme, Boudewijn Van, Vanrenterghem, Yves F. Ch

Volltext

Association of Treatment Effects on Early Change in Urine Protein and Treatment Effects on GFR Slope in IgA Nephropathy: An Individual Participant Meta-analysis von Inker, Lesley A., Heerspink, Hiddo J.L., Tighiouart, Hocine, Chaudhari, Juhi, Miao, Shiyuan, Diva, Ulysses, Mercer, Alex, Appel, Gerald B., Donadio, James V., Floege, Jürgen, Li, Philip K.T., Maes, Bart D., Locatelli, Francesco, Praga, Manuel, Schena, Francesco P., Levey, Andrew S., Greene, Tom

Volltext

Change in Albuminuria and GFR Slope as Joint Surrogate End Points for Kidney Failure: Implications for Phase 2 Clinical Trials in CKD von Heerspink, Hiddo J L, Inker, Lesley A, Tighiouart, Hocine, Collier, Willem H, Haaland, Benjamin, Luo, Jiyu, Appel, Gerald B, Chan, Tak Mao, Estacio, Raymond O, Fervenza, Fernando, Floege, Jürgen, Imai, Enyu, Jafar, Tazeen H, Lewis, Julia B, Kam-Tao Li, Philip, Locatelli, Francesco, Maes, Bart D, Perna, Annalisa, Perrone, Ronald D, Praga, Manuel, Schena, Francesco P, Wanner, Christoph, Xie, Di, Greene, Tom

Volltext

Observational study on the incidence of nephrogenic systemic fibrosis in patients with renal impairment following gadoterate meglumine administration: the NSsaFe study von McWilliams, Richard G., Frabizzio, Jennifer V., De Backer, Adelard I., Grinberg, Anna, Maes, Bart D., Zobel, Bruno Beomonte, Gottschalk, Andreas

Volltext

Evaluation of Variation in the Performance of GFR Slope as a Surrogate End Point for Kidney Failure in Clinical Trials that Differ by Severity of CKD von Collier, Willem, Inker, Lesley A, Haaland, Benjamin, Appel, Gerald B, Badve, Sunil V, Caravaca-Fontán, Fernando, Chalmers, John, Floege, Jürgen, Goicoechea, Marian, Imai, Enyu, Jafar, Tazeen H, Lewis, Julia B, Li, Philip K T, Locatelli, Francesco, Maes, Bart D, Neuen, Brendon L, Perrone, Ronald D, Remuzzi, Giuseppe, Schena, Francesco P, Wanner, Christoph, Heerspink, Hiddo J L, Greene, Tom

Volltext

Differential Effect of Diarrhea on FK506 Versus Cyclosporine A Trough Levels and Resultant Prevention of Allograft Rejection in Renal Transplant Recipients von Maes, Bart D., Lemahieu, Wim, Kuypers, Dirk, Evenepoel, Pieter, Coosemansc, Willy, Pirenne, Jacques, Vanrenterghem, Yves F. CH

Volltext

Comparison of peritoneal dialysis and haemodialysis after renal transplant failure von de Jonge, Hylke, Bammens, Bert, Lemahieu, Wim, Maes, Bart D., Vanrenterghem, Yves

Volltext

Erosive enterocolitis in mycophenolate mofetil-treated renal-transplant recipients with persistent afebrile diarrhea von MAES, Bart D, DALLE, Ignace, VANRENTERGHEM, Yves F. Ch, GEBOES, Karen, OELLERICH, Michael, ARMSTRONG, Victor W, EVENEPOEL, Pieter, GEYPENS, Benny, KUYPERS, Dirk, SHIPKOVA, Maria, GEBOES, Karel

Volltext

Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test von Ghoos, Yvo F., Maes, Bart D., Geypens, Benny J., Mys, Geert, Hiele, Martin I., Rutgeerts, Paul J., Vantrappen, Gaston

Volltext

The value of tuberculin skin testing in haemodialysis patients von Wauters, Anne, Peetermans, Willy E., Van den Brande, Paul, De Moor, Bart, Evenepoel, Pieter, Keuleers, Hilde, Kuypers, Dirk, Stas, Koen, Vanwalleghem, Johan, Vanrenterghem, Yves, Maes, Bart D.

Volltext

Atacicept 150 mg Reduces Serum Gd-IgA1, a Biomarker Associated with Long-Term Outcomes in IgA Nephropathy (IgAN): 36W Results from the Ph2b ORIGIN Study: SA-PO887 von Barratt, Jonathan, Maes, Bart D., Lin, Celia J., Wei, Xuelian, Barbour, Sean, Phoon, Richard K., Kim, Sung Gyun, Tesar, Vladimir, Floege, Jürgen, Jha, Vivekanand, Lafayette, Richard A.

Volltext

Atacicept in IgA Nephropathy (IgAN): Continued Protective Titers to Diphtheria and Tetanus and Balanced Infections vs. Placebo with a Focus on COVID-19: SA-PO884 von Barratt, Jonathan, Maes, Bart D., Israni, Rubeen K., Wei, Xuelian, Tesar, Vladimir, Appel, Gerald B., Suzuki, Yusuke, Lin, Celia J., Lafayette, Richard A.

Volltext

Impact of gastric acid suppressants on cytochrome P450 3A4 and P-glycoprotein: Consequences for FK506 assimilation von Lemahieu, Wim P.D., Maes, Bart D., Verbeke, Kristin, Vanrenterghem, Yves

Volltext

Effect of Iptacopan on Proteinuria and Complement Biomarkers Over Time in IgA Nephropathy: FR-OR59 von Rovin, Brad H., Barratt, Jonathan, Zhang, Hong, Rizk, Dana, Kashihara, Naoki, Maes, Bart D., Trimarchi, Hernan, Sprangers, Ben, Meier, Matthias, Kollins, Dmitrij, Magirr, Annabel R., Junge, Guido, Perkovic, Vlado

Volltext

Alterations of CYP3A4 and P-glycoprotein activity in vivo with time in renal graft recipients von Lemahieu, Wim P.D., Maes, Bart D., Verbeke, Kirstin, Vanrenterghem, Yves F.Ch

Volltext

Reply from the Authors von Maes, Bart D., Vanrenterghem, Yves F.Ch

Volltext